Celldex Therapeutics, Inc

(NASDAQ:CLDX)

Latest On Celldex Therapeutics, Inc (CLDX):

Date/Time Type Description Signal Details
2023-05-18 18:33 ESTNewsCelldex Therapeutics: Revolutionizing Cancer Care With Innovative ImmunotherapiesN/A
2023-05-04 23:29 ESTNewsCelldex GAAP EPS of -$0.62, revenue of $1MN/A
2023-03-02 14:39 ESTNewsCelldex Therapeutics (CLDX) Presents At AAAAI ConferenceN/A
2023-02-28 18:15 ESTNewsCelldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35MN/A
2023-02-27 12:59 ESTNewsCelldex gains 12% on Phase 1 data for urticaria candidateN/A
2023-02-20 07:02 ESTNewsCelldex: Long List Of Failures, High Valuation, But Good Data RecentlyN/A
2022-12-02 20:42 ESTNewsCelldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis)N/A
2022-11-09 22:05 ESTNewsCelldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05MN/A
2022-08-09 00:09 ESTNewsCelldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24MN/A
2022-07-22 13:36 ESTNewsCelldex begins dosing in mid-stage study of barzolvolimab for skin disorderN/A
2022-07-14 20:11 ESTNewsCelldex: Barzolvolimab Plus Bispecific Antibodies AdvancementN/A
2022-07-01 20:44 ESTNewsCelldex posts early-stage data to support dose-dependent effect of urticaria therapyN/A
2022-05-06 00:47 ESTNewsCelldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39MN/A
2022-03-01 04:31 ESTNewsCelldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84MN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 08:33 ESTNewsCelldex Q4 2021 Earnings PreviewN/A
2022-02-17 13:49 ESTNewsCelldex Therapeutics (CLDX) Investor Presentation - SlideshowN/A
2022-02-01 06:48 ESTNewsCelldex: Pipeline Of Drug Candidates Is Worth A LookN/A
2021-11-12 18:41 ESTNewsCelldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody programN/A
2021-11-10 04:54 ESTNewsCelldex EPS misses by $0.09, misses on revenueN/A
2021-09-29 12:19 ESTNewsCelldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patientsN/A
2021-09-24 01:18 ESTNewsCelldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-MakersN/A
2021-08-06 00:09 ESTNewsCelldex EPS beats by $0.06, beats on revenueN/A
2021-07-22 20:52 ESTNewsCelldex rises with bullish call from Guggenheim; potential of lead asset citedN/A
2021-07-21 00:15 ESTNewsCelldex: Powerful Medicines To Yield Further UpsidesN/A
2021-07-21 00:14 ESTNewsCelldex gains over a third on early-stage data for CDX-0159 in skin conditionN/A
2021-07-21 00:13 ESTNewsAnimal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst actionN/A
2021-07-21 00:13 ESTNewsTempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losersN/A
2021-07-21 00:12 ESTNewsCelldex Therapeutics proposes $175M capital raiseN/A
2021-07-21 00:12 ESTNewsCelldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The BeginningN/A
2021-07-21 00:10 ESTNewsCelldex Therapeutics raises $250M via equity offeringN/A
2021-05-07 05:42 ESTNewsCelldex EPS misses by $0.08, misses on revenueN/A
2021-03-30 03:43 ESTNewsCelldex EPS misses by $0.18, beats on revenueN/A
2021-03-29 08:13 ESTNewsCelldex reports 80% complete response rate in CDX-0159 study in skin allergyN/A
2021-03-02 07:24 ESTAnalyst RatingThe Analyst Target Price has increased from $30.67 to $34.33.Buy
2021-02-24 03:23 ESTAnalyst RatingThe Analyst Target Price has increased from $26.33 to $30.67.Buy
2021-02-22 18:38 ESTNewsCelldex to expand development of CDX-0159 into prurigo nodularisN/A
2021-01-17 17:51 ESTNewsCelldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And MoreN/A
2020-12-13 03:34 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 15:50 ESTNewsDosing underway in Celldex's CDX-0159 study in skin allergyN/A
2020-11-19 19:29 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $26.33.Buy
2020-11-10 03:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:34 ESTAnalyst RatingThe Analyst Target Price has increased from $21.5 to $23.5.Buy
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:23 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 04:46 ESTNewsCelldex EPS in-line, beats on revenueN/A
2020-11-01 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $21.5.Buy
2020-10-14 09:13 ESTNewsDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder studyN/A

About Celldex Therapeutics, Inc (CLDX):

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX Quotes by TradingView

See Advanced Chart

General

  • Name Celldex Therapeutics, Inc
  • Symbol CLDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:15
  • Last Split Date2019-02-11
  • Fiscal Year EndDecember
  • IPO Date2008-03-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.celldex.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 133.88
  • Price/Book (Most Recent Quarter) 4.37
  • Enterprise Value Revenue 186.73
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -1150%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 4.52 million
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.19
  • Gross Profit -39099000
  • Quarterly Earnings Growth 22.3%
View More

Highlights

  • Market Capitalization 988.78 million
  • EBITDA -51311000
  • PE Ratio -18.24
  • Analyst Target Price $34.33
  • Book Value Per Share $5.81
View More

Share Statistics

  • Shares Outstanding 39.57 million
  • Shares Float 28.85 million
  • % Held by Insiders 16%
  • % Held by Institutions 82.07%
  • Shares Short 2.87 million
  • Shares Short Prior Month 3.44 million
  • Short Ratio 4.18
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.73
  • 52 Week High $30.17
  • 52 Week Low $1.51
  • 50 Day Moving Average 25.2
  • 200 Day Moving Average 18.9
View More

Dividends

  • Dividend Date 2019-02-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Celldex Therapeutics, Inc (CLDX) Dividend Calendar:

CLDX's last dividend payment was made to shareholders on February 11, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Celldex Therapeutics, Inc (CLDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$668000-$0.36-$0.360%
2020-06-302020-08-06$N/A-$0.50-$0.5813.79%
2020-03-312020-05-06$2.73 million-$0.73-$0.70-4.29%
2019-12-312020-03-26$887000-$0.64-$0.9331.18%
2019-09-302019-11-12$546000-$0.75-$0.8410.71%
2019-06-302019-08-07$715000-$0.84-$1.1728.21%
2019-03-312019-05-07$1.43 million-$1.40-$1.14-22.81%
2018-12-312019-03-07$1.76 million-$0.81-$1.2032.5%
2018-09-302018-11-07$941000-$0.60-$2.2573.33%
2018-06-302018-08-08$2.76 million-$1.65-$2.5535.29%
2018-03-312018-05-10$4.07 million-$12.60-$3.03-315.84%
2017-12-312018-03-07$3.46 million-$0.45-$3.7387.92%
2017-09-302017-11-07$3.92 million-$3.00-$3.9824.53%
2017-06-302017-08-08$3.83 million-$3.45-$4.0915.71%
2017-03-312017-05-09$1.53 million-$4.20-$4.281.75%
2016-12-312017-03-14$1.87 million-$4.50-$5.0510.89%
2016-09-302016-11-07$2.22 million-$4.35-$4.9712.42%
2016-06-302016-08-08$1.39 million-$4.80-$5.054.95%
2016-03-312016-05-05$1.3 million-$5.25-$5.24-0.29%
2015-12-312016-02-23$1.79 million-$4.95-$5.204.81%
2015-09-302015-11-05$1.03 million-$0.32-$0.358.57%
2015-06-302015-08-10$2.18 million-$0.33-$0.342.94%
2015-03-312015-04-29$486000-$0.33-$0.368.33%
2014-12-312015-02-24$1.48 million-$0.36-$0.35-2.86%
2014-09-302014-11-05$1.1 million-$0.31-$0.336.06%
2014-06-302014-08-06$592000-$4.80-$4.840.83%
2014-03-312014-05-01$416000-$4.95-$3.94-25.63%
2013-12-312014-03-03$620000-$4.05-$4.183.11%
2013-09-302013-11-08$980000-$4.35-$3.66-18.85%
2013-06-302013-08-06$97000-$3.60-$3.34-7.78%
2013-03-312013-05-02$2.41 million-$3.45-$3.30-4.55%
2012-12-312013-03-07$3.65 million-$4.05-$3.75-8%
2012-09-302012-11-01$3.11 million-$3.75-$3.62-3.59%
2012-06-302012-08-10$2.01 million-$3.45-$3.798.97%
2012-03-312012-05-03$2.43 million-$4.05-$3.57-13.45%
2011-12-312012-03-07$2.43 million-$4.35-$4.17-4.32%
2011-09-302011-11-02$2.36 million-$4.05-$3.84-5.47%
2011-06-302011-08-03$1.95 million-$4.05-$4.295.59%
2011-03-312011-05-04$2.52 million-$4.65-$4.54-2.42%
2010-12-312011-03-03$2.13 million-$3.60$3.15-214.29%
2010-09-302010-11-02$2.41 million-$4.35-$4.8710.68%
2010-06-302010-08-04$2.95 million-$4.50-$3.95-13.92%
2010-03-312010-05-04$3.71 million-$3.15-$3.9520.25%
2009-12-312010-03-04$4.73 million-$6.45-$4.30-50%
2009-09-302009-11-04$4.03 million-$6.75-$8.3218.87%
2009-06-302009-08-05$2.69 million-$8.25-$7.10-16.2%
2009-03-312009-05-05$3.73 million-$7.35-$6.90-6.52%
2008-12-312009-02-27$2.99 million-$7.05-$8.1012.96%
2008-09-302008-11-05$2.36 million-$7.50-$7.20-4.17%
2008-06-302008-08-06$1.96 million-$10.05-$8.40-19.64%
2008-03-312008-05-19$147000-$32.85-$9.97-229.49%
2007-12-312008-02-27$384000-$26.19
2007-09-302007-10-31$269000-$12.60-$12.600%
2007-06-302007-08-02$609000-$12.60-$18.0030%
2007-03-312007-05-03$144000-$87.35
2006-12-312007-03-07$255000-$14.40-$14.400%
2006-09-302006-11-01$199000-$14.40-$12.60-14.29%
2006-06-302006-08-02$317000-$14.40-$12.60-14.29%
2006-03-312006-05-09$128000-$7.20-$5.40-33.33%
2005-12-312006-03-08$36000-$9.00-$10.8016.67%
2005-09-302005-10-27$23000-$10.80-$12.6014.29%
2005-06-302005-08-03$12000-$10.80-$6.30-71.43%
2005-03-312005-05-05$N/A-$12.60-$11.70-7.69%
2004-12-312005-03-02-$9.00-$10.8016.67%
2004-09-302004-10-20-$8.98
2004-06-302004-07-22-$9.00-$9.000%
2004-03-312004-04-21-$5.40-$9.0040%
2003-12-312004-02-24-$9.00-$9.000%
2003-09-302003-10-22-$5.40-$10.8050%
2003-06-302003-07-23-$9.48
2003-03-312003-04-30-$10.01
2002-12-312003-02-26-$10.80-$12.6014.29%
2002-09-302002-10-23-$1.80-$16.2088.89%
2002-06-302002-07-24-$16.20-$17.105.26%
2002-03-312002-04-24-$14.40-$18.0020%
2001-12-312002-02-26-$19.80-$20.402.94%
2001-09-302001-10-25-$19.80-$23.4015.38%
2001-06-302001-08-02-$18.00-$22.8021.05%
2001-03-312001-04-25-$12.60-$16.2022.22%
2000-12-312001-03-01-$14.40-$13.50-6.67%
2000-09-302000-10-25-$12.60-$12.600%
2000-06-302000-06-30-$9.79
2000-03-312000-04-27-$7.20-$10.8033.33%
1996-12-311997-02-19-$16.20-$18.0010%
1996-09-301996-11-06-$18.00-$18.000%
1996-06-301996-07-23-$39.60-$18.00-120%
1995-12-311996-02-27-$28.80-$25.20-14.29%
1995-09-301995-11-10-$32.40-$27.00-20%
1995-06-301995-08-11-$27.00-$25.20-7.14%
1995-03-311995-05-12-$25.20-$23.40-7.69%
1994-12-311995-02-15-$19.80-$35.1043.59%
1994-09-301994-11-10-$23.40-$24.303.7%
1994-06-301994-08-02-$23.40-$25.207.14%
1994-03-311994-05-02-$19.80-$25.2021.43%
1993-09-301993-10-29-$27.00-$21.60-25%
1993-03-311993-05-12-$23.40-$18.00-30%

Celldex Therapeutics, Inc (CLDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 10.71 million N/A 11.7 million N/A 11.1 million
Income Before Tax -14.22 million N/A -12.63 million -10.45 million -11.41 million
Selling General Administrative 4.3 million N/A 3.67 million 3.22 million 3.4 million
Gross Profit 668000 N/A N/A -9.45 million 546000
Ebit -14.22 million N/A -11.47 million -12.67 million -13.96 million
Operating Income -14.34 million N/A -12.63 million -12.67 million -13.96 million
Income Tax Expense N/A -228000 N/A N/A N/A
Total Revenue 668000 N/A 2.73 million 887000 546000
Cost of Revenue N/A N/A N/A 10.34 million N/A
Total Other Income Expense Net N/A N/A 8000 2.22 million 2.55 million
Net Income From Continuing Operations -14.22 million N/A -12.63 million -10.45 million -11.41 million
Net Income Applicable to Common Shares -14.22 million -11.03 million -12.63 million -10.45 million -11.41 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -42.36 million N/A 21.97 million 3.33 million 5.64 million
Change to Liabilities 1.04 million 599000 N/A 563000 714000
Total Cash Flow from Investing Activities -42.51 million -108.53 million N/A 3.22 million 5.52 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 4.49 million N/A 1.64 million 2.42 million 2.46 million
Change to Operating Activities N/A -1.29 million N/A -2.95 million -357000
Change in Cash -49.88 million N/A 11.49 million -5.35 million -3.16 million
Total Cash from Operating Activities -11.86 million -11.22 million -12.11 million -11 million -11.14 million
Depreciation 774000 N/A 1.17 million 1.15 million 1.21 million
Other Cash Flow from Investing Activities 9000 N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A -161000 443000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 1.9 million -1.43 million N/A 849000 -1.74 million
Capital Expenditures 160000 N/A 235000 105000 142000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 25.8 million N/A 28.8 million 28.91 million 30.46 million
Total Stockholder Equity 229.98 million N/A 83.7 million 94.03 million 101.38 million
Other Current Liabilities 3.63 million N/A 1.99 million 2.03 million 2.55 million
Total Assets 255.77 million N/A 112.5 million 122.93 million 131.84 million
Common Stock 40000 39000 83.7 million 17000 16000
Other Current Assets 2.49 million N/A N/A N/A N/A
Retained Earnings -1.05 billion -1.04 billion -1.03 billion -1.01 billion -1 billion
Other Liabilities N/A 10.4 million 17.87 million 15.55 million 17.09 million
Other Assets N/A 41000 N/A 41000 129000
Cash 18.15 million N/A 22.72 million 11.23 million 16.59 million
Total Current Liabilities 12.2 million N/A 10.93 million 11.64 million 11.89 million
Other Stockholder Equity 2.61 million 2.59 million N/A 2.62 million 2.64 million
Property, Plant & Equipment 3.81 million 7.18 million 4.12 million 7.5 million 7.92 million
Total Current Assets 202.93 million N/A 55.92 million 66.7 million 75.1 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 184.79 million 193.25 million 31.23 million 45.34 million 52.69 million
Short Term Investments 181.44 million N/A 31 million 53.15 million 56.33 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 8.58 million N/A 1.61 million 1.17 million 666000

Celldex Therapeutics, Inc (CLDX) Chart:

Celldex Therapeutics, Inc (CLDX) News:

Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Celldex Therapeutics, Inc (CLDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-17150CALL0 0144.55TRUE00
2026-04-17160CALL0 0131.15TRUE00
2026-04-17170CALL0 0118.55TRUE00
2026-04-17180CALL0 0106.66TRUE00
2026-04-17190CALL0 00TRUE00
2026-04-17200CALL0 084.65TRUE00
2026-04-17210CALL0 00TRUE00
2026-04-17220CALL0 0122.09TRUE00
2026-04-17230CALL0 0109.58TRUE00
2026-04-17240CALL0 069.2TRUE00
2026-04-17250CALL0 068.53TRUE00
2026-04-17263.66CALL0 169.58TRUE00
2026-04-17274.5CALL0 270.01TRUE00
2026-04-17285.32CALL0 1381.22TRUE00
2026-04-17293.45CALL0 3566.71TRUE00
2026-04-17302.6CALL0 488.59TRUE00
2026-04-17312CALL0 292.22TRUE00
2026-04-17321.5CALL0 2688.33FALSE00
2026-04-17331CALL0 252.66FALSE00
2026-04-17340.73CALL0 2875.15FALSE00
2026-04-17350.85CALL0 15095.88FALSE00
2026-04-17361.05CALL0 165.82FALSE00
2026-04-17370.36CALL0 2113.78FALSE00
2026-04-17380CALL0 0137.52FALSE00
2026-04-17390CALL0 0122.84FALSE00
2026-04-17400.5CALL0 50135.77FALSE00
2026-04-17410CALL0 0143.4FALSE00
2026-04-17420CALL0 0211.36FALSE00
2026-04-17430CALL0 0219.12FALSE00
2026-04-17440CALL0 0169.61FALSE00
2026-04-17450CALL0 098.97FALSE00
2026-04-17150PUT0 0452.03FALSE00
2026-04-17160PUT0 0421.41FALSE00
2026-04-17170PUT0 0392.91FALSE00
2026-04-17180PUT0 0366.22FALSE00
2026-04-17190PUT0 0341.06FALSE00
2026-04-17200PUT0 0317.23FALSE00
2026-04-17210PUT0 0294.54FALSE00
2026-04-17220PUT0 0272.83FALSE00
2026-04-17230PUT0 0251.95FALSE00
2026-04-17240PUT0 0231.77FALSE00
2026-04-17250PUT0 0212.17FALSE00
2026-04-17260PUT0 0193.02FALSE00
2026-04-17270.6PUT0 20174.19FALSE00
2026-04-17280.96PUT0 7155.53FALSE00
2026-04-17291.19PUT0 10161.07FALSE00
2026-04-17301.31PUT0 350.83FALSE00
2026-04-17311.95PUT0 598.27FALSE00
2026-04-17320PUT0 077.1TRUE00
2026-04-17330PUT0 055.01TRUE00
2026-04-17340PUT0 046.68TRUE00
2026-04-17350PUT0 057.43TRUE00
2026-04-17360PUT0 050.05TRUE00
2026-04-17370PUT0 057.07TRUE00
2026-04-17380PUT0 057.75TRUE00
2026-04-17390PUT0 075.14TRUE00
2026-04-17400PUT0 058.53TRUE00
2026-04-17410PUT0 063.42TRUE00
2026-04-17420PUT0 068.14TRUE00
2026-04-17430PUT0 072.7TRUE00
2026-04-17440PUT0 00TRUE00
2026-04-17450PUT0 00TRUE00
2026-05-151510.4CALL0 1132.38TRUE00
2026-05-15160CALL0 0121.72TRUE00
2026-05-15170CALL0 0111.73TRUE00
2026-05-15180CALL0 0102.31TRUE00
2026-05-15190CALL0 093.41TRUE00
2026-05-152013.21CALL0 2589.39TRUE00
2026-05-15210CALL0 076.88TRUE00
2026-05-15220CALL0 069.16TRUE00
2026-05-15238.5CALL0 065.42TRUE00
2026-05-15240CALL0 069.2TRUE00
2026-05-15256.95CALL0 17550.83TRUE00
2026-05-15260CALL0 061.39TRUE00
2026-05-15275.49CALL0 569.26TRUE00
2026-05-15286.51CALL0 1766.17TRUE00
2026-05-15293.84CALL0 166.63TRUE00
2026-05-15303.95CALL0 669.27TRUE00
2026-05-15312.6CALL0 273.92TRUE00
2026-05-15322.3CALL0 3365.07FALSE00
2026-05-15331.1CALL0 372.46FALSE00
2026-05-15341.05CALL0 258.79FALSE00
2026-05-15351.5CALL4 19064.68FALSE-0.1-0.06
2026-05-15361.9CALL0 664.79FALSE00
2026-05-15371.1CALL0 463.14FALSE00
2026-05-15380CALL0 064.77FALSE00
2026-05-15391.15CALL0 170.48FALSE00
2026-05-15400.69CALL0 3384.27FALSE00
2026-05-15411.05CALL0 188.2FALSE00
2026-05-15421CALL0 191.88FALSE00
2026-05-15430.5CALL0 295.34FALSE00
2026-05-15440.45CALL0 1132.15FALSE00
2026-05-15450.45CALL0 9102.48FALSE00
2026-05-15150.5PUT0 26194.34FALSE00
2026-05-15160.6PUT0 17181.94FALSE00
2026-05-15170.6PUT0 30173.01FALSE00
2026-05-15180.65PUT0 18170.57FALSE00
2026-05-15191.3PUT0 10200.3FALSE00
2026-05-15201.15PUT0 7180.37FALSE00
2026-05-15211.7PUT0 6178.35FALSE00
2026-05-15220PUT0 0165.26FALSE00
2026-05-15230.63PUT0 9115.27FALSE00
2026-05-15242.35PUT0 23140.51FALSE00
2026-05-15250.75PUT0 12128.7FALSE00
2026-05-15263.9PUT0 1117.17FALSE00
2026-05-15270PUT0 0105.83FALSE00
2026-05-15280PUT0 094.6FALSE00
2026-05-15293.6PUT0 283.37FALSE00
2026-05-15305.83PUT0 1071.99FALSE00
2026-05-15310PUT0 061.96FALSE00
2026-05-15320PUT0 060.84TRUE00
2026-05-15330PUT0 059.53TRUE00
2026-05-15340PUT0 052.54TRUE00
2026-05-15357.58PUT0 1246.29TRUE00
2026-05-15360PUT0 029.99TRUE00
2026-05-15370PUT0 057.82TRUE00
2026-05-15380PUT0 063.05TRUE00
2026-05-15390PUT0 050.93TRUE00
2026-05-15400PUT0 055.03TRUE00
2026-05-15410PUT0 058.96TRUE00
2026-05-154211.25PUT0 156.69TRUE00
2026-05-15430PUT0 066.35TRUE00
2026-05-15440PUT0 063.43TRUE00
2026-05-15450PUT0 066.64TRUE00
2026-08-21150CALL0 071.01TRUE00
2026-08-21160CALL0 086.14TRUE00
2026-08-21170CALL0 079.22TRUE00
2026-08-21180CALL0 074.58TRUE00
2026-08-21190CALL0 076.46TRUE00
2026-08-21200CALL0 075.7TRUE00
2026-08-21210CALL0 070.66TRUE00
2026-08-21220CALL0 074.72TRUE00
2026-08-21239.85CALL0 20083.06TRUE00
2026-08-21249.2CALL0 3872.58TRUE00
2026-08-21258.76CALL0 3875.56TRUE00
2026-08-21260CALL0 070.45TRUE00
2026-08-21273CALL0 070.71TRUE00
2026-08-21282.77CALL0 168.28TRUE00
2026-08-21290CALL0 070.5TRUE00
2026-08-21303.7CALL0 170.78TRUE00
2026-08-21315.1CALL0 766.67TRUE00
2026-08-21322.9CALL0 166.25FALSE00
2026-08-21332.5CALL0 167.08FALSE00
2026-08-21342.15CALL0 171.1FALSE00
2026-08-21352CALL0 366.09FALSE00
2026-08-21363.58CALL0 567.53FALSE00
2026-08-21370CALL0 071.93FALSE00
2026-08-21380CALL0 062.98FALSE00
2026-08-21390CALL0 062.19FALSE00
2026-08-21403.1CALL0 358.24FALSE00
2026-08-21410CALL0 066.75FALSE00
2026-08-21420CALL0 061.55FALSE00
2026-08-21430CALL0 072.14FALSE00
2026-08-21441.95CALL0 157.8FALSE00
2026-08-21451.75CALL0 179.24FALSE00
2026-08-21151.6PUT0 9123.68FALSE00
2026-08-21160.75PUT0 3143.28FALSE00
2026-08-21170.8PUT0 3133.7FALSE00
2026-08-21180.9PUT0 10124.72FALSE00
2026-08-21191.8PUT0 2116.28FALSE00
2026-08-21201.95PUT0 1108.27FALSE00
2026-08-21210PUT0 0100.66FALSE00
2026-08-21223PUT0 5093.38FALSE00
2026-08-21230PUT0 086.38FALSE00
2026-08-21242.75PUT0 179.62FALSE00
2026-08-21250PUT0 074.33FALSE00
2026-08-21260PUT0 067.87FALSE00
2026-08-21270PUT0 069.2FALSE00
2026-08-21280PUT0 068.81FALSE00
2026-08-21290PUT0 068.34FALSE00
2026-08-21305PUT0 066.79FALSE00
2026-08-21310PUT0 062.9FALSE00
2026-08-21320PUT0 067.23TRUE00
2026-08-21330PUT0 065.9TRUE00
2026-08-21340PUT0 064.22TRUE00
2026-08-21350PUT0 065.42TRUE00
2026-08-21360PUT0 063.04TRUE00
2026-08-21377.9PUT0 261.6TRUE00
2026-08-21380PUT0 063.83TRUE00
2026-08-21390PUT0 064.47TRUE00
2026-08-21400PUT0 067.64TRUE00
2026-08-21410PUT0 063.56TRUE00
2026-08-21420PUT0 066.38TRUE00
2026-08-21430PUT0 061.36TRUE00
2026-08-21440PUT0 063.87TRUE00
2026-08-21450PUT0 065.47TRUE00
2026-10-161517CALL0 298.18TRUE00
2026-10-16200CALL0 087.81TRUE00
2026-10-16210CALL0 089.17TRUE00
2026-10-16220CALL0 084.19TRUE00
2026-10-16230CALL0 084TRUE00
2026-10-16240CALL0 082.71TRUE00
2026-10-16250CALL0 083.97TRUE00
2026-10-162610.07CALL0 184.11TRUE00
2026-10-16270CALL0 085.22TRUE00
2026-10-16280CALL0 086.59TRUE00
2026-10-16290CALL0 083.97TRUE00
2026-10-16300CALL0 083.61TRUE00
2026-10-16317.4CALL0 184.75TRUE00
2026-10-16320CALL0 079.38FALSE00
2026-10-16330CALL0 079.55FALSE00
2026-10-16340CALL0 081.72FALSE00
2026-10-16350CALL0 079.27FALSE00
2026-10-16360CALL0 080.48FALSE00
2026-10-16370CALL0 082.6FALSE00
2026-10-16385CALL0 283.46FALSE00
2026-10-16390CALL0 080.89FALSE00
2026-10-16404.6CALL0 381.44FALSE00
2026-10-16410CALL0 083.5FALSE00
2026-10-16424CALL0 181.31FALSE00
2026-10-16430CALL0 080.91FALSE00
2026-10-16440CALL0 077.84FALSE00
2026-10-16450CALL0 078.86FALSE00
2026-10-16150PUT0 0130.75FALSE00
2026-10-16200PUT0 092.37FALSE00
2026-10-16210PUT0 087.23FALSE00
2026-10-16220PUT0 081.41FALSE00
2026-10-16230PUT0 082.82FALSE00
2026-10-16240PUT0 080.74FALSE00
2026-10-16250PUT0 079.88FALSE00
2026-10-16260PUT0 083.4FALSE00
2026-10-16270PUT0 077.68FALSE00
2026-10-16280PUT0 080.4FALSE00
2026-10-16290PUT0 079.66FALSE00
2026-10-16305.94PUT0 576.63FALSE00
2026-10-16310PUT0 075.2FALSE00
2026-10-16320PUT0 078.08TRUE00
2026-10-16330PUT0 078.97TRUE00
2026-10-16340PUT0 077.97TRUE00
2026-10-16359.7PUT0 476.77TRUE00
2026-10-16360PUT0 073.75TRUE00
2026-10-16370PUT0 077.1TRUE00
2026-10-16380PUT0 075.34TRUE00
2026-10-16390PUT0 078.34TRUE00
2026-10-16400PUT0 077.34TRUE00
2026-10-16410PUT0 076.17TRUE00
2026-10-16420PUT0 075.39TRUE00
2026-10-16430PUT0 076.72TRUE00
2026-10-16440PUT0 074.47TRUE00
2026-10-16450PUT0 074.37TRUE00
2026-11-20150CALL0 0120.97TRUE00
2026-11-202015.7CALL0 2127.75TRUE00
2026-11-20210CALL0 0127.9TRUE00
2026-11-20220CALL0 0127.03TRUE00
2026-11-20230CALL0 0125.28TRUE00
2026-11-20240CALL0 0126.84TRUE00
2026-11-202514.95CALL0 2126.77TRUE00
2026-11-20260CALL0 0123.93TRUE00
2026-11-20270CALL0 0122.32TRUE00
2026-11-20280CALL0 0123.07TRUE00
2026-11-20290CALL0 0123.62TRUE00
2026-11-20300CALL0 0122.83TRUE00
2026-11-20310CALL0 0121.35TRUE00
2026-11-20320CALL0 0120.93FALSE00
2026-11-203311.9CALL0 3122.06FALSE00
2026-11-20340CALL0 0119.75FALSE00
2026-11-203510.4CALL0 4123.36FALSE00
2026-11-20368.9CALL0 2118.73FALSE00
2026-11-20378.3CALL0 3118.88FALSE00
2026-11-20389.6CALL0 5121.55FALSE00
2026-11-20397.7CALL0 4117.84FALSE00
2026-11-204010CALL0 5115.14FALSE00
2026-11-20410CALL0 0114.96FALSE00
2026-11-20429.8CALL0 5114.69FALSE00
2026-11-204310.1CALL0 7111.82FALSE00
2026-11-20447.7CALL0 2113.93FALSE00
2026-11-20458CALL0 13113.45FALSE00
2026-11-20150PUT0 0124.26FALSE00
2026-11-20200PUT0 0120.53FALSE00
2026-11-20210PUT0 0120.54FALSE00
2026-11-20220PUT0 0121FALSE00
2026-11-20230PUT0 0124.68FALSE00
2026-11-20240PUT0 0123.79FALSE00
2026-11-20250PUT0 0122.74FALSE00
2026-11-20260PUT0 0118.37FALSE00
2026-11-20270PUT0 0120.25FALSE00
2026-11-20288.5PUT0 1116.42FALSE00
2026-11-20290PUT0 0120.87FALSE00
2026-11-20300PUT0 0119.18FALSE00
2026-11-20310PUT0 0118.55FALSE00
2026-11-20320PUT0 0116.14TRUE00
2026-11-203311.9PUT0 4112.58TRUE00
2026-11-203412.7PUT0 4117.1TRUE00
2026-11-203513.3PUT0 12116.58TRUE00
2026-11-203614.5PUT0 5114.9TRUE00
2026-11-20370PUT0 0116.29TRUE00
2026-11-203815PUT0 1114.44TRUE00
2026-11-20390PUT0 0113.56TRUE00
2026-11-204017.2PUT0 4115.67TRUE00
2026-11-20410PUT0 0112.56TRUE00
2026-11-204218.7PUT0 3110.93TRUE00
2026-11-20430PUT0 0113.28TRUE00
2026-11-20440PUT0 0108.46TRUE00
2026-11-20450PUT0 0110.65TRUE00
2026-12-181320.8CALL0 35140.49TRUE00
2026-12-18150CALL0 0136.53TRUE00
2026-12-18180CALL0 0135.03TRUE00
2026-12-182018.25CALL0 1135.61TRUE00
2026-12-182217.1CALL0 15135.14TRUE00
2026-12-182517CALL0 1130.87TRUE00
2026-12-182713.6CALL0 22130.85TRUE00
2026-12-18306.5CALL0 10128.66TRUE00
2026-12-183210CALL0 3128.58FALSE00
2026-12-183511.7CALL0 141128.25FALSE00
2026-12-183712.2CALL0 1126.23FALSE00
2026-12-184010.34CALL0 14128.77FALSE00
2026-12-184211CALL0 4125.12FALSE00
2026-12-184510.5CALL0 54124.69FALSE00
2026-12-18130PUT0 0131.8FALSE00
2026-12-18150PUT0 0136.69FALSE00
2026-12-18180PUT0 0135.05FALSE00
2026-12-18200PUT0 0132.47FALSE00
2026-12-18220PUT0 0128.63FALSE00
2026-12-18250PUT0 0128.99FALSE00
2026-12-18278.4PUT0 1142128.96FALSE00
2026-12-18300PUT0 0126.45FALSE00
2026-12-18320PUT0 0125.24TRUE00
2026-12-183515.39PUT0 12126.68TRUE00
2026-12-183716PUT0 6124.56TRUE00
2026-12-184017.9PUT0 20125.16TRUE00
2026-12-184218.9PUT0 9123.39TRUE00
2026-12-184520.94PUT0 2121.53TRUE00
2027-01-151320.98CALL0 2130.78TRUE00
2027-01-151519.58CALL0 1129.32TRUE00
2027-01-151818.2CALL0 24128.74TRUE00
2027-01-152018.2CALL0 3130.72TRUE00
2027-01-152311.64CALL0 6129.24TRUE00
2027-01-152514.35CALL0 14125.89TRUE00
2027-01-15270CALL0 0128.13TRUE00
2027-01-15300CALL0 0127.44TRUE00
2027-01-15320CALL0 0122.97FALSE00
2027-01-15350CALL0 0123.12FALSE00
2027-01-15370CALL0 0121.66FALSE00
2027-01-154010.63CALL0 5125.01FALSE00
2027-01-15420CALL0 0122.42FALSE00
2027-01-154510.5CALL0 20119.19FALSE00
2027-01-15130PUT0 0134.61FALSE00
2027-01-15150PUT0 0131.67FALSE00
2027-01-15180PUT0 0131.11FALSE00
2027-01-15205.5PUT0 2128.45FALSE00
2027-01-15235.5PUT0 10126.2FALSE00
2027-01-15250PUT0 0124.84FALSE00
2027-01-15278PUT0 1126.48FALSE00
2027-01-153011.5PUT0 32122.28FALSE00
2027-01-15320PUT0 0122.65TRUE00
2027-01-153510.11PUT0 6121.43TRUE00
2027-01-153711.39PUT0 1121.87TRUE00
2027-01-15400PUT0 0119.55TRUE00
2027-01-154220.66PUT0 25119.29TRUE00
2027-01-154522.9PUT0 1120.3TRUE00

Latest CLDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$20.54
Jun 13, 2022 7:59 PM EST61$20.52
Jun 13, 2022 7:59 PM EST28$20.52
Jun 13, 2022 7:59 PM EST1$20.51
Jun 13, 2022 7:59 PM EST190$20.54

Celldex Therapeutics, Inc (CLDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm
2020-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm
2020-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm
2018-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm
2019-12-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm
2019-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm
2019-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm
2020-06-15S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm
2018-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm
2020-06-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm
2018-04-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm

Celldex Therapeutics, Inc (CLDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 16%
Institutional Ownership: 8207%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-09Margo Heath-ChiozziSVP of Regulatory AffairsBuy1,000.003.013,005.001,000.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-09Samuel Bates MartinSVP and CFOBuy9,750.003.0529,737.5010,735.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-09JAMES J MARINODirectorBuy8,305.003.0024,915.0012,704.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-10Sarah CavanaughSVP of Corp Affairs & Admin.Buy1,050.004.835,071.501,367.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-09Anthony S MarucciPresident & CEOBuy15,000.003.0645,900.0019,438.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-11Diane C. YoungSVP, Chief Medical OfficerBuy2,115.004.7310,003.952,115.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2018-06-15TIBOR KELERExecutive VP & CSOBuy16,500.000.599,782.8535,368.00https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-08-24JAMES J MARINODirectorBuy40,000.000.4819,200.0065,997.00https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2020-06-09TIBOR KELERExecutive VP & CSOBuy5,000.002.9914,954.007,357.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm